Gene Query: MOB1A

Dataset Description Geneva Score
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 107.78
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 107.78
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 33.84
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 32.02
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 32.02
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 31.01
RIG-I and MDA5 fRIP during KSHV lytic reactivation 28.68
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 27.65
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 24.03
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 22.94
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 22.51
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 21.87
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 21.54
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 21.54
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 21.53
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 21.38
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 21.38
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 21.29
Triple vectors expand AAV transfer capacity in the retina 21.25
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 21.12
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 21.12
Ribosomal footprinting of CN34-Parental and CN34-LM1a 21.05
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 20.71
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 19.98
IMP3 regulated gene expression in breast cancer cells 19.36
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 18.87
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 18.74
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 18.56
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 18.45
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 18.35
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 18.29
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 18.29
Sensing self and nonself circular RNAs 18.21
Human cell line and subcutaneous tumor 18.18
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 18.08
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 17.74
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 17.67
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 17.67
Ribosomal footprinting of MDA-Parental and MDA-LM2 17.62
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 17.45
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 17.34
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 17.33
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 17.18
Role of XRN2 ribonucleolytic activity in RNA metabolism 16.96
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 16.94
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 16.74
TFAP2C signalling in human fibroblasts 16.08
Genome wide expression change in LCC2 and MCF-7 cells 15.55
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 15.27
3’ Uridylation Expands miRNA Target Repertoire 15.0
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 14.99
MYCi975 regulates MYC target genes 14.65
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 14.58
Transcriptome analysis in Neobractatin treated cells 14.57
LncRNA-GAS5 negative regulation of YAP-target genes expression 14.57
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 14.43
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 14.43
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 14.34
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 14.26
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 13.79
HNRNPL and its RNA Targets in Prostate Cancer 13.77
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 13.77
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 13.51
Solid phase chemistry to covalently and reversibly capture thiolated RNA 13.25
Survival of pancreatic cancer cells lacking KRAS function 13.14
NRDE2 negatively regulates nuclear exosome functions 13.12
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 13.09
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 13.06
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 13.06
Human cells contain natural double-stranded RNAs with potential regulatory capacity 12.96
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 12.94
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 12.91
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 12.87
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 12.87
Cajal bodies are linked to genome conformation 12.57
Cajal bodies are linked to genome conformation [RNA-Seq] 12.57
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 12.43
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 12.4
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 12.35
METTL3 promotes translation in human cancer cells 12.27
Co-transcriptional loading of RNA export factors shapes the human transcriptome 12.19
RNAseq of HEK293 cells after Chtop knockdown 12.19
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 12.16
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 12.13
RNA-seq analyses of human prostate cancer cells 11.98
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 11.96
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 11.95
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 11.92
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 11.89
Targeting EZH2 in MYCN-amplified Neuroblastoma 11.81
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 11.81
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 11.79
Cleavage Factor Im as a key regulator of 3’ UTR length 11.77
Trans-differentiation of human adult peripheral blood T cells into neurons 11.73
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 11.71
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 11.69
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 11.69
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 11.65
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 11.65
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 11.59
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 11.57
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 11.49
MYC dependent mRNA translation shapes gene expression and cell biology 11.47
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 11.39
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 11.32
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 11.24
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 11.24
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 11.24
Role of microRNAs in the interaction between Salmonella and the host cell 11.23
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 11.16
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 11.09
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 11.03
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 10.86
Co-regulation of splicing by Rbfox1 and hnRNP M 10.86
SLAM-seq for K562 endogenous mRNA decay 10.77
Zika infected neural stem cells 10.73
Transcriptome analysis of Zika infected neural stem cells 10.73
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 10.52
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 10.52
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 10.52
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 10.45
Exploring the RNA landscape of endothelial exosomes 10.45
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 10.41
An RNA-centric dissection of host complexes controlling flavivirus infection 10.41
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 10.41
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 10.41
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 10.39
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 10.36
Short and Long RNA sequencing of human mature erythrocytes 10.34
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 10.33
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 10.33
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 10.18
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 10.11
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 10.07
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 10.03
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 10.03
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 10.02
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 10.01
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 9.97
CROP-Seq in Primary Human T Cells 9.9
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 9.89
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 9.88
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 9.83
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 9.79
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 9.74
Determination of tRNA aminoacylation levels by high throughput sequencing 9.71
K562 polyA RNA-Seq 9.64
The human blood-nerve barrier transcriptome 9.63
RNAseq Analysis in glioblastoma cells treated with Mepazine 9.63
Profiling of escape kinetics of viruses subjected to RNAi 9.6
Transcriptome profiling of Normal and Cancerous Prostate Cells 9.58
Mapping interactions for the TNIP2 hub protein 9.48
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 9.44
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 9.44
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 9.4
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 9.4
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 9.35
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 9.34
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 9.33
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 9.31
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 9.26
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 9.26
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 9.23
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 9.22
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 9.15
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 9.15
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 9.13
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 9.13
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 9.09
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 9.06
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 9.06
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 9.04
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 9.03
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 8.98
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 8.94
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 8.91
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 8.91
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 8.9
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 8.88
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 8.87
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 8.87
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 8.84
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 8.81
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 8.72
Widespread regulated alternative splicing of single codons accelerates proteome evolution 8.72
Identification of the role of polydom in neurofibromas 8.7
Comprehensive comparative analysis of 5’ end RNA sequencing methods 8.69
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.63
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 8.61
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 8.58
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 8.54
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 8.47
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 8.36
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 8.31
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 8.31
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 8.27
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 8.25
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 8.24
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 8.19
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 8.19
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 8.15
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 8.14
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 8.11
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.1
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 7.95
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 7.91
Effect of from Human Umbilical Vein Endothelial Cells 7.88
Systematic discovery of endogenous human ribonucleoprotein complexes 7.78
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 7.78
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 7.77
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 7.74
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 7.74
Genes significantly down or Up-regulated upon RNF219 knockdown 7.72
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 7.71
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 7.71
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 7.68
Interaction between mitoNEET and NAF-1 in cancer cells 7.67
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 7.64
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 7.62
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 7.59
RNA-Seq with and without RNase treatment in PCa cell lines 7.56
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 7.55
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 7.55
Expression by CD133+ cells isolated from the adult human exocrine pancreas 7.55
Novel Targeting of Transcription and Metabolism in Glioblastoma 7.47
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 7.45
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 7.41
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 7.41
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 7.39
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 7.37
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 7.3
Unique features and clinical importance of acute alloreactive immune responses 7.24
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 7.22
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 7.22
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 7.11
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 7.11
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 7.1
RNA-seq of RKO cells with cTAZ KO or putback 7.1
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 6.97
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 6.94
RNA-sequencing in irradiated and normal A549 cells. 6.91
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 6.91
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 6.81
miR-93 Targets in Human Endothelial Cells 6.81
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 6.74
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 6.74
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 6.7
Transcriptomic analysis of the HOTAIR-regulated genes 6.7
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 6.7
Comparative Analysis of Cas9 Activators Across Multiple Species 6.69
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 6.69
Analysis of transcriptional regulation by Myt1 and Myt1l 6.66
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 6.65
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 6.61
U1 snRNP telescripting regulates size-function stratified human genome 6.6
RNA polymerase in pre-B-ALL cell lines 6.51
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 6.5
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 6.4
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 6.4
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 6.31
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 6.31
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 6.26
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 6.2
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 6.2
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 6.18
Transcriptomic analysis of human tonsillar TFH subsets 6.14
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 6.13
Regulation of protein translation during mitosis 6.12
Regulation of highly expressed hCINAP on translatome 6.11
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 6.05
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 5.93
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 5.9
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 5.9
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 5.88
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 5.86
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 5.86
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 5.84
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 5.8
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 5.7
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.62
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.62
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 5.59
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 5.49
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 5.48
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 5.48
The cohesin release factor WAPL restricts chromatin loop extension. 5.45
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 5.45
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 5.4
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 5.39
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 5.39
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 5.35
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 5.29
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 5.14
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 5.11
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 5.1
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 5.06
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 5.03
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 5.03
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 5.0
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 4.99
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 4.99
The transcriptome effect of overexpressing EZH2 in MCF7 4.96
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 4.96
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 4.96
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 4.9
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 4.84
Small-molecule targeting of brachyury transcription factor addiction in chordoma 4.83
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 4.8
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 4.74
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 4.67
Global response to chemotherapy-induced apoptosis 4.61
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 4.46
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 4.37
Identification of renal resident macrophages across species 4.34
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 4.33
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.33
Differential gene expression profiles in imatinib-resistant cell lines 4.33
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 4.32
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 4.29
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 4.26
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 4.22
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 4.22
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 4.22
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 4.22
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 4.16
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 4.13
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 4.1
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 4.1
Searching for target genes of miR-508/509/506/514 in HCT116 cells 4.03
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 4.02
CDK4/6 inhibitor resistance in prostate cancer 3.98
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 3.95
Regulatory network controlling tumor-promoting inflammation in human cancers 3.93
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 3.93
Next generation sequencing of small RNAs isolated from exosomes in human semen 3.9
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 3.88
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 3.87
Copper Regulation of HIF-1 Transcription Activity 3.82
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 3.82
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 3.71
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 3.67
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 3.63
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 3.58
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.57
Identification of a LIF-responsive replication-competent human β cell 3.56
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 3.52
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 3.5
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.49
Transcriptome sequencing of K-562 cells 3.49
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 3.49
Transcription elongation regulates genome 3D structure 3.47
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 3.45
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 3.45
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.44
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 3.38
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 3.38
Role of cervicovaginal microbiota in genital inflammation 3.37
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 3.35
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 3.31
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.28
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 3.24
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 3.01
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 3.01
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.01
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.01
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 3.0
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 2.97
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 2.94
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 2.93
Transcriptome analysis of CNS leukemia 2.91
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 2.91
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 2.87
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.81
CDK12 mediated transcriptional regulation in U2OS cells 2.8
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 2.77
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 2.77
mRNA recovered upon RNF219 IP. [RNA-IP] 2.72
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 2.71
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 2.71
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 2.71
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 2.66
RNA-Seq of PRMT1 overexpression ECA109 cells 2.65
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 2.61
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 2.57
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.55
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 2.55
Mitochondrial dsRNA triggers antiviral signalling in humans 2.54
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.48
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 2.47
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 2.45
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.38
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 2.36
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 2.35
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.34
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 2.26
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 2.26
Human Tfh cell RNA bulk sequencing 2.23
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.17
O-glcnAc reprograms cellular energetics 2.16
Measure transcript integrity using RNA-seq data 2.11
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 2.06
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 2.05
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 2.04
Transcriptome analysis of peripheral blood monocytes 1.91
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.9
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.9
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 1.85
Modulation of nonsense-mediated decay by rapamycin 1.82
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.76
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 1.74
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.64
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.62
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.62
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.61
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 1.6
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 1.6
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.56
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 1.53
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 1.52
Myc activation coordinates gene transcription and protein translation responses 1.5
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.49
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 1.48
Transcriptome-wide response to synthetic chromatin protein PcTF 1.47
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.46
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.41
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.41
6mer seed toxicity in viral microRNAs 1.4
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.38
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.38
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 1.35
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.33
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.3
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.3
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.29
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 1.29
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.27
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.27
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.27
Transposon-based construction of strand-specific RNA-seq libraries 1.18
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 1.17
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 1.17
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 1.14
Discovering human diabetes-risk gene function with genetics and physiological assays 1.13
HBEC-shp53-PCHD7 1.13
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.08
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.03
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 1.02
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 1.01
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.98
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.94
KSDM1b Role in Ewing Sarcoma 0.89
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.88
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.83
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.81
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.81
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.8
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.78
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 0.78
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 0.78
High-resolution comparative analysis of great ape genomes 0.75
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.74
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.72
Identification of renal resident macrophages across species [C1] 0.72
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.71
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.71
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.7
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.7
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.65
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 0.64
Aneuploidy-induced cellular stresses limit autophagic degradation. 0.61
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.56
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 0.55
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.51
Dermal endothelial cells of type 2 diabetic patients 0.51
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.43
RNA-seq data 0.42
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.42
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.39
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.38
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.38
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.38
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 0.37
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.34
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.33
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.31
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.29
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.28
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.27
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.24
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.23
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.23
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.22
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.17
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.12
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.1
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.09
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.06
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.01
Iron response of HepG2 cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation